<DOC>
	<DOC>NCT02272569</DOC>
	<brief_summary>Prospective, Non-comparative, Multi-center clinical trial to evaluate the safety and efficacy of the STARflo Glaucoma Implant in patients with refractory open angle glaucoma.</brief_summary>
	<brief_title>STARflo European Safety and Efficacy Study</brief_title>
	<detailed_description>This is a prospective, multicenter clinical trial to assess the efficacy and the safety of the STARflo™ Glaucoma Implant. Patients will enter the study after providing written informed consent. Patients will be screened to confirm that they are eligible for study participation. When eligibility has been established using the in/exclusion criteria, surgery will be scheduled. Pre and post-surgery, patients will be evaluated at scheduled intervals (1 day, 1 week, 1 month, 3 months, 6 months, 12 months) for a total duration of 12 months following surgery.</detailed_description>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma, Open-Angle</mesh_term>
	<criteria>Main Diagnosis of refractory open angle glaucoma Documented 21 mmHg &lt; IOP ≤ 40 mmHg, under medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>glaucoma</keyword>
	<keyword>glaucoma drainage device</keyword>
	<keyword>glaucoma shunt</keyword>
</DOC>